Surgical pharmacy for catalyzing pharmacy service throughout surgical continuum

Abstract

The greater the complementarity between pharmacists’ knowledge and doctors’ knowledge, the more significant the role pharmacists can play in clinical practice. Physicians extensively use drugs for disease management and are well-versed in the medications related to their specialties. Conversely, surgeons often prioritize surgical procedures over medication, which can lead to more frequent irrational drug uses in surgical departments compared to internal medicine department. Given this, pharmacists could play a pivotal role in surgical departments. In 2018, the Guangdong Province Pharmaceutical Association (GDPA) in China advocated for the establishment of surgical pharmacist in hospitals. Surgical pharmacists are tasked with overseeing all aspects of medication management during the perioperative period and beyond and serve as a bridge between surgeons and physicians. The GDPA has established "surgical pharmacy" as a distinct knowledge system for surgical pharmacists, which is defined as a specialty that studies the characteristics of surgical medication, seeks the most suitable medication therapy and addresses medication-related problems for surgical patients to improve clinical outcomes. Focus on perioperative medications, such as anti-infection, anti-thrombosis, analgesia, nutrition, blood sugar, blood pressure, fluid, nausea and vomiting management, and glucocorticoid use. In Guangdong province, many major hospitals have now established surgical pharmacist positions, accepted by surgeons and physicians. Unlike pharmacists in surgical settings outside of China, those endorsed by the GDPA engage directly in patient care through collaborative drug therapy management (CDTM), positioning them as integral members of the surgical team alongside surgeons and anesthetists rather than members of the multidisciplinary team, having their own specialty - "surgical pharmacy". Thereby surgeons concentrate on surgical procedures and anesthetists on anesthesia, while pharmacists focus on medication therapy. This delineation enhances the efficiency and effectiveness of patient care in surgical departments.

Keywords

Surgical pharmacy / Surgical pharmacist / Pharmacy service / Surgery / Collaborative drug therapy management (CDTM)

Declarations

Not applicable.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Declaration of Competing Interest

The author declares that there is no competing interests.

Acknowledgements

I express my thanks to hospital chief pharmacists Junyan Wu, Li Wei, Ruolun Wang, Yingtong Zeng, Xiaoyan Li, Bo Ji, Jisheng Chen, Tao Liu, Xiao Chen, Yilei Li, Hongwei Wu, Jinghao Wang, Shuyao Zhang, Jie Chen, Wenying Chen, Hongmei Tang, Shanshan Yu, Chen Yang, and to Wang Yong, director of the academic department at Guangdong Province Pharmaceutical Association, for their assistance in the preparation of this article.

Authors' other information

Not applicable.

References

[1] Thomson C, Gunther M, Macek P. Clinical pharmacists in correctional facilities: a literature review and future directions. J Correct Health Care. 2019; 25(3):201-213. https://doi.org/10.1177/1078345819852044

[2] Wash A, Moczygemba LR, Anderson L, et al. Pharmacists' intention to prescribe under new legislation. Res Social Adm Pharm. 2022; 18(5):2837-2847. https://doi.org/10.1016/j.sapharm.2021.06.017

[3] Kennedy MJ. Personalized medicines - are pharmacists ready for the challenge? Integr Pharm Res Pract. 2018; 7:113-123. https://doi.org/10.2147/IPRP.S133083

[4] Wireko AA, Ohenewaa Tenkorang P, Tope Adebusoye F, et al. The importance of pharmacists in modern day surgery - editorial. Int J Surg. 2023; 109(2):88-90. https://doi.org/10.1097/JS9.0000000000000146

[5] Achong MR, Hauser BA, Krusky JL. Rational and irrational use of antibiotics in a Canadian teaching hospital. Can Med Assoc J. 1977; 116(3):256-259.

[6] Eleni A, Dimitrios Z, Aikaterini G, et al. The impact of irrational perioperative antibiotic prophylaxis on the nursing workload. Health Science Journal. 2015; 9(1):1-5.

[7] Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Expert Rev Clin Pharmacol. 2018; 11(11):1123-1134. https://doi.org/10.1080/17512433.2018.1531703

[8] Gauger EM, Gauger EJ, Desai MJ, et al. Opioid Use After Upper Extremity Surgery. J Hand Surg Am. 2018; 43(5):470-479. https://doi.org/10.1016/j.jhsa.2018.02.026

[9] Mohseni S, Behnam-Roudsari S, Tarbiat M, et al. Perioperative hypertension etiologies in patients undergoing noncardiac surgery in university health network hospitals - Canada from 2015 - 2020. Integr Blood Press Control. 2022; 15:23-32. https://doi.org/10.2147/IBPC.S347395

[10] Wang R, Liu B, Feng X, et al. The effect of pharmacist-initiated perioperative multidisciplinary pharmaceutical care model and clinical pathway on pain management in patients undergoing orthopedic surgery: a before-after study. Int J Clin Pharm. 2023; 45(4):929-939. https://doi.org/10.1007/s11096-023-01575-z

[11] Zheng Z, Wu J, Zeng Y, et al. Creating the position of surgical pharmacist in China. Eur J Hosp Pharm. 2020; 27(6):e99. https://doi.org/10.1136/ejhpharm-2020-002238

[12] Zheng Z, Wu J, Zeng Y, et al. “surgical pharmacist” (Chinese). Promoting the establishment of the position of Pharmacy Today. 2020; 30(4):259-260+271. https://doi.org/10.12048/j.issn.1674-229X.2020.04.012

[13] Wu J, Zhang M, Wang R, et al. Surgical pharmacy: knowledge construction for surgical pharmacists (Chinese). Pharmacy Today. 2021; 31(1):1-8. https://doi.org/10.12048/j.issn.1674-229X.2021.01.001

[14] Zheng Z, Wu J, Wei L, et al. Surgical pharmacy: the knowledge system of surgical pharmacists. Eur J Hosp Pharm. 2023; 30(1):e2. https://doi.org/10.1136/ejhpharm-2021-002887

[15] Xie J, Huang X, Gao M, et al. Surgical pharmacy for optimizing medication therapy management services within enhanced recovery after surgery (ERAS®) programs. J Clin Med. 2023; 12(2):631. https://doi.org/10.3390/jcm12020631

[16] Australian Diabetes Society. Peri-operative diabetes management guidelines 2012. Available from: https://www.diabetessociety.com.au/documents/PerioperativeDiabetesManagementGuidelinesFINALCleanJuly2012.pdf.

[17] Legrand M. Should renin-angiotensin system inhibitors be held prior to major surgery? Br J Anaesth. 2024; 132(5):831-834. https://doi.org/10.1016/j.bja.2024.03.003

[18] Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anaesthesia. Anesth Analg. 1999; 89(5):1143-1155.

[19] Guangdong Province Pharmaceutical Association. Medical-pharmaceutical expert consensus on perioperative blood glucose management (Chinese). Pharmacy Today. 2018; 28(2):73-83. https://doi.org/10.12048/j.issn.1674-229X.2018.02.001

[20] Guangdong Province Pharmaceutical Association. Medical-pharmaceutical expert consensus on perioperative blood pressure management(Chinese). Pharmacy Today. 2019; 29(5):289-303. https://doi.org/10.12048/j.issn.1674-229X.2019.05.001

[21] Guangdong Province Pharmaceutical Association. Clinical pharmacists guidelines for postoperative pain management (Chinese). Pharmacy Today. 2019; 29(4):217-227. https://doi.org/10.12048/j.issn.1674-229X.2019.04.001

[22] Guangdong Province Pharmaceutical Association. Consensus on clinical pharmacy practice of parenteral and enteral nutritionlz (2022) (Chinese). Pharmacy Today. 2023; 33(6):414-421. https://doi.org/10.12048/j.issn.1674-229X.2023.06.002

[23] Zheng Z, Huang H, Wang Y, et al. Spread of the idea of 'deprescribing' in China. Eur J Hosp Pharm. 2019; 26(4):241-242.

[24] Wu J, Zeng Y, Wei L, et al. Surgical pharmacy. Beijing: China Medical Science Press; 2021.

[25] He Q, Wu J. Severe Surgical Infection and Drug Treatment. Beijing: People’s Medical Publishing House; 2021.

[26] Tang H, Zheng Z. Surgical Pharmacy of Chinese Medicine. Beijing: China Medical Science Press; 2024.

[27] Tang H, Lu Q, Feng S, et al. Guidelines for the clinical application of the Xihuang pill for the prevention and treatment of breast hyperplasia diseases. Pharm Biol. 2024; 62(1):472-479. https://doi.org/10.1080/13880209.2024.2350233

[28] Liu T, Liu S, Wei X, et al. Exploration of the working mode of oncology surgical pharmacy (Chinese). Pharmacy Today. 2021; 31(7):501-507. https://doi.org/10.12048/j.issn.1674-229X.2021.07.004

[29] Liu T, Zhang Y, Fang C, et al. Working mode of oncology surgical pharmacy in China. Farm Hosp. 2022; 46(4):256-259.

[30] Neville HL, Chevalier B, Daley C, et al. Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital. Int J Pharm Pract. 2014; 22(3):216-222. https://doi.org/10.1111/ijpp.12058

[31] Morin NP. A pharmacist-led practice to improve perioperative glycemic control in elective surgery. Clin Diabetes. 2023; 41(3):446-451. https://doi.org/10.2337/cd21-0139

[32] Bansal N, Tai WT, Chen LC. Implementation of an innovative surgical pharmacy service to improve patient outcomes-Twelve-month outcomes of the enhanced surgical medicines optimization service. J Clin Pharm Ther. 2019; 44(6):904-911. https://doi.org/10.1111/jcpt.13014

[33] Molloy T. The diversity of patients is vast’ - a day in the life of a perioperative prescribing pharmacist. The Pharmaceutical Journal. 2020; 305(7940) https://doi.org/10.1211/PJ.2020.20208231

[34] Ngige G, Carton E, Zaborowski A, et al. 4CPS-239 Evaluation of clinical pharmacist interventions in surgical patients. Eur J Hosp Pharm. 2018; 25(1):A152-A153. https://doi.org/10.1136/ejhpharm-2018-eahpconf.329

[35] Léguillon R, Varin R, Pressat-Laffouilhère T, et al. Clinical pharmacist intervention reduces potentially inappropriate prescriptions in a geriatric perioperative care unit dedicated to hip fracture. Gerontology. 2023; 69(4):386-395. https://doi.org/10.1159/000526595

[36] Axelsen T, Nielsen K, Jepsen H, et al. Prescription and administration of medicine in a surgical department. Clinical pharmacists increase the safety of medical treatment of surgical patients. Eur J Hosp Pharm. 2012; 19(2):231-232. https://doi.org/10.1136/ejhpharm-2012-000074.383

[37] Bickham P, Golembiewski J, Meyer T, et al. ASHP guidelines on perioperative pharmacy services. Am J Health Syst Pharm. 2019; 76(12):903-920. https://doi.org/10.1093/ajhp/zxz073

[38] Bui T, Fitzpatrick B, Forrester T, et al. Standard of practice in surgery and perioperative medicine for pharmacy services. J Pharm Practice Res. 2022; 52(2):139-158. https://doi.org/10.1002/JPPR.1805

[39] Patel G, Hyland S, Birrer K, et al. Perioperative clinical pharmacy practice: responsibilities and scope within the surgical care continuum. J Am Coll Clin Pharm. 2019; 3(2):501-519. https://doi.org/10.1002/jac5.1185

[40] Lovely JK, Hyland SJ, Smith AN, et al. Clinical pharmacist perspectives for optimizing pharmacotherapy within enhanced recovery after surgery (ERASR®) programs. Int J Surg. 2019; 63:58-62. https://doi.org/10.1016/j.ijsu.2019.01.006

[41] Gemensky J. The pharmacist’s role in surgery: the indispensable asset. U. S. Pharm. 2015; 40(3):HS8-HS12.

[42] Parrish II RH, Bodenstab HM, Carneal D, et al. Positive patient postoperative outcomes with pharmacotherapy: a narrative review including perioperative-specialty pharmacist interviews. J Clin Med. 2022; 11(19):5628. https://doi.org/10.3390/jcm11195628

[43] Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy. Pharmacotherapy. 1997; 17(5):1050-1061.

[44] Lovely JK, Larson DW, Quast JM. A clinical practice agreement between pharmacists and surgeons streamlines medication management. Jt Comm J Qual Patient Saf. 2014; 40(7):296-302.

[45] Hale A, Coombes I, Stokes J, et al. Patient satisfaction from two studies of collaborative doctor-pharmacist prescribing in Australia. Health Expect. 2016; 19(1):49-61. https://doi.org/10.1111/hex.12329

[46] Hale A, Merlo G, Nissen L, et al. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients. BMC Health Ser Res. 2018; 18(1):749. https://doi.org/10.1186/s12913-018-3557-0